Immune Regulation News Volume 15.00 | Jan 6 2023

    0
    105








    2023-01-06 | IRN 15.00


    Immune Regulation News by STEMCELL Technologies
    Vol. 15.00 – 6 January, 2023
    TOP STORY

    Protection of Cell Therapeutics from Antibody-Mediated Killing by CD64 Overexpression

    In three applications of the approach, human CD64t-engineered thyroid epithelial cells, pancreatic beta cells, and CAR T cells withstood clinically relevant levels of graft-directed antibodies and fully evaded antibody-mediated killing.
    [Nature Biotechnology]

    Full ArticlePress Release
    Daniel Grey investigates cell death modification as a potential therapy for immune disorders. View his profile.
    PUBLICATIONSRanked by the impact factor of the journal

    Deletion of PD-1 Destabilizes the Lineage Identity and Metabolic Fitness of Tumor-Infiltrating Regulatory T Cells

    In Pdcd1fl/flFoxp3eGFP−Cre-ERT2(+/−) mice, in which both PD-1-expressing and PD-1-deficient Treg cells coexisted in the same tissue environment, conditional deletion of PD-1 in Treg cells resulted in impairment of the proliferative and suppressive capacity of tumor infiltrating Treg cells.
    [Nature Immunology]

    Abstract

    SREBP Signaling Is Essential for Effective B Cell Responses

    To investigate the role of sterol regulatory binding protein (SREBP) signaling in modulating immune responses, researchers generated mice with B cell- or CD11c+ antigen-presenting cell-specific deletion of SCAP, an essential regulator of SREBP signaling.
    [Nature Immunology]

    Abstract

    Biomarker-Responsive Engineered Probiotic Diagnoses, Records, and Ameliorates Inflammatory Bowel Disease in Mice

    Scientists developed an engineered probiotic that noninvasively monitored and recorded inflammatory bowel disease occurrence and progression in real time, and could release treatments via a self-tunable mechanism in response to these biomarkers.
    [Cell Host & Microbe]

    AbstractGraphical Abstract

    Engineering Human Stem Cell-Derived Islets to Evade Immune Rejection and Promote Localized Immune Tolerance

    The authors demonstrated that targeting human leukocyte antigens and PD-L1 alone did not sufficiently protect stem cell-derived islet cells from xenograft- or allograft-rejection.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract

    Anti-Tumor Immunity Enhancement by Photodynamic Therapy with Talaporfin Sodium and Anti-Programmed Death 1 Antibody

    Talaporfin sodium photodynamic therapy (TS-PDT) induced apoptosis, necrosis, and autophagy-associated cell death were tested in vitro. Tumor growth was inhibited in the TS-PDT and anti-PD-1 antibody combination group, compared with other single treatment or non-treatment groups, in vivo.
    [Molecular Therapy-Oncolytics]

    Full ArticleGraphical Abstract

    A Bioengineered Probiotic for the Oral Delivery of a Peptide Kv1.3 Channel Blocker to Treat Rheumatoid Arthritis

    Scientists developed a genetically engineered probiotic delivery system that delivered a peptide to the intestinal tract with high efficacy. They constructed an inducible system in the probiotic Lactobacillus reuteri to secrete the Kv1.3 potassium blocker ShK-235.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Abstract

    Chemokine CXCL4 Interactions with Extracellular Matrix Proteoglycans Mediate Widespread Immune Cell Recruitment Independent of Chemokine Receptors

    The authors demonstrated that CXCL4 binds to glycosaminoglycan sugars on proteoglycans within the endothelial extracellular matrix, resulting in increased adhesion of leukocytes to the vasculature, increased vascular permeability, and non-specific recruitment of a range of leukocytes.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Neutrophils and Macrophages Drive TNF-Induced Lethality via TRIF/CD14-Mediated Responses

    In a murine TNF–induced sepsis model, TRIF and CD14 deficiency decreased systemic inflammation, reduced organ pathology, and improved survival.
    [Science Immunology]

    AbstractPress Release
    Find the Right Antibodies for Your Stem Cell Research. Learn More
    REVIEWS

    TH17 Cell Heterogeneity and Its Role in Tissue Inflammation

    The authors discuss the heterogeneity of interleukin-17-producing CD4+ T cells (TH17), and the role of this heterogeneity in diverse functions of TH17 cells from homeostasis to tissue inflammation.
    [Nature Immunology]

    Full Article
    INDUSTRY AND POLICY NEWS

    BioNTech Partnering With UK Government on Personalized mRNA Cancer Immunotherapies

    BioNTech has signed a memorandum of understanding with the UK government. The aim is to provide personalized cancer therapies for up to 10,000 patients by the end of 2030, either through clinical trials or as authorized treatments.
    [BioNTech]

    Press Release

    STEMCELL Technologies President and CEO Dr. Allen Eaves Appointed to the Order of Canada

    STEMCELL Technologies announced that its President and CEO, Dr. Allen Eaves, has been appointed to the Order of Canada by Her Excellency the Right Honorable Mary Simon, the Governor General of Canada.
    [STEMCELL Technologies]

    Press Release
    FEATURED EVENT

    Next Generation Antibody Therapeutics: From Discovery to Patient

    February 19 – 22, 2023
    Banff, Alberta, Canada

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Asthma and Allergy

    University of California, San Diego – La Jolla, California, United States

    European Market Development Manager – Immunology

    STEMCELL Technologies – St. Egreve, France

    Postdoctoral Fellow – Inflammation & Immunology

    Pfizer – Cambridge, Massachusetts, United States

    Senior Scientist – Vaccine Immunology

    Pfizer – Pearl River, New York, United States

    Clinical Trialist – Rheumatology

    Oklahoma Medical Research Foundation – Oklahoma City, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immune Regulation News Twitter